Company DarioHealth Corp.

Equities

DRIO

US23725P2092

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 21:30:00 03/05/2024 BST 5-day change 1st Jan Change
1.57 USD +3.29% Intraday chart for DarioHealth Corp. +6.08% -8.72%

Business Summary

DarioHealth Corp. is a global digital therapeutics (DTx) company. The Company operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutic interventions. Its platform and suite of solutions delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its products include Dario Blood Pressure Monitoring System and Dario Blood Glucose Monitoring Starter Kit. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows to store all its user readings in the Dario App. Its Dario mobile app is a complete, cloud-based solution for personal chronic condition management.

Number of employees: 285

Sales per Business

USD in Million2022Weight2023Weight Delta
Services
64.3 %
18 64.6 % 13 64.3 % -26.74%
Consumer Hardware
35.7 %
10 35.4 % 7 35.7 % -25.81%

Sales per region

USD in Million2022Weight2023Weight Delta
Global
100.0 %
28 100.0 % 20 100.0 % -26.41%

Managers

Managers TitleAgeSince
Chief Executive Officer 51 30/09/12
Founder - 10/08/11
Director of Finance/CFO 63 06/01/15
President 55 06/01/20
Chief Tech/Sci/R&D Officer - 31/01/21
Compliance Officer - 31/08/20
Chief Tech/Sci/R&D Officer - 25/03/20
Chief Tech/Sci/R&D Officer - 31/01/19
Chief Operating Officer 53 02-14
Investor Relations Contact - 30/06/22

Members of the board

Members of the board TitleAgeSince
Director/Board Member 67 11/11/13
Director/Board Member 60 26/10/11
Chairman 52 04/07/18
Director/Board Member 55 22/11/14
Director/Board Member 63 01/07/20
Chief Executive Officer 51 30/09/12
Director/Board Member 56 22/02/23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 29,666,750 25,305,140 ( 85.30 %) 0 85.30 %
Stock B 0 18,959 0 0

Shareholders

NameEquities%Valuation
Nantahala Capital Management LLC
8.591 %
2,336,753 8.591 % 4 M $
1,912,059 7.029 % 3 M $
Appian Way Asset Management LP
4.862 %
1,322,444 4.862 % 2 M $
1,288,518 4.737 % 2 M $
MORE Investment House Ltd.
4.737 %
1,288,518 4.737 % 2 M $
1,180,813 4.341 % 2 M $
Kershner Trading Americas LLC
3.871 %
1,053,024 3.871 % 2 M $
875,964 3.220 % 1 M $
747,821 2.749 % 1 M $
Vanguard Global Advisers LLC
1.335 %
363,042 1.335 % 555 454 $

Company contact information

DarioHealth Corp.

322 W 57th Street Suite 33B

10019, New York

+

http://www.dariohealth.com
address DarioHealth Corp.(DRIO)
  1. Stock Market
  2. Equities
  3. DRIO Stock
  4. Company DarioHealth Corp.